Filing Details
- Accession Number:
- 0001179110-10-015426
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-11-01 18:41:53
- Reporting Period:
- 2010-10-28
- Filing Date:
- 2010-11-01
- Accepted Time:
- 2010-11-01 18:41:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882095 | Gilead Sciences Inc | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198229 | Paul Berg | Beckman Center, Rm. B062 Stanford University School Of Medicine Stanford CA 94305 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-10-28 | 8,006 | $39.82 | 32,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale prices reported for the transaction reported here range from $39.81 to $39.82. Full information regarding the number of shares purchased or sold at each price will be provided to the SEC, the issuer or its shareowners upon request.